Education
About Us
Working with TipRanks
Follow Us
Accelerate Diagnostics, Inc. (AXDXQ)
OTHER OTC:AXDXQ
AXDXQ Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $2.09
Previous CloseN/A
VolumeN/A
Average Volume (3M)3.78M
Market Cap
$25.00
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.04
Next Earnings
Aug 07, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding54,516,000
10 Day Avg. Volume142,852
30 Day Avg. Volume3,776,765
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Sell
Number of Analyst Covering0
Accelerate Diagnostics News
AXDXQ FAQ
What was Accelerate Diagnostics, Inc.’s price range in the past 12 months?
Accelerate Diagnostics, Inc. lowest stock price was <$0.01 and its highest was $2.09 in the past 12 months.
What is Accelerate Diagnostics, Inc.’s market cap?
Accelerate Diagnostics, Inc.’s market cap is $25.00.
When is Accelerate Diagnostics, Inc.’s upcoming earnings report date?
Accelerate Diagnostics, Inc.’s upcoming earnings report date is Aug 07, 2025 which is 31 days ago.
How were Accelerate Diagnostics, Inc.’s earnings last quarter?
Currently, no data Available
Is Accelerate Diagnostics, Inc. overvalued?
According to Wall Street analysts Accelerate Diagnostics, Inc.’s price is currently Overvalued.
Does Accelerate Diagnostics, Inc. pay dividends?
Accelerate Diagnostics, Inc. does not currently pay dividends.
What is Accelerate Diagnostics, Inc.’s EPS estimate?
Accelerate Diagnostics, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Accelerate Diagnostics, Inc. have?
Accelerate Diagnostics, Inc. has 54,516,000 shares outstanding.
What happened to Accelerate Diagnostics, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Accelerate Diagnostics, Inc.?
Currently, no hedge funds are holding shares in AXDXQ
Company Description
Accelerate Diagnostics, Inc.
Accelerate Diagnostics (AXDXQ) is a healthcare technology company focused on improving the diagnosis of infectious diseases. The company specializes in the development and commercialization of innovative diagnostic solutions that enhance the speed and accuracy of pathogen identification and antibiotic susceptibility testing. Its core product offerings include the Accelerate Arc system and related assays, which are designed to deliver rapid results for critical care settings and support healthcare providers in making informed treatment decisions.
Technical Analysis
Ownership Overview
37.88% Insiders
1.89% Mutual Funds
<0.01% Other Institutional Investors
60.23% Public Companies and
Individual Investors